Cornerstone Advisors, LLC Biogen Inc. Transaction History

Cornerstone Advisors, LLC

$2.45 Billion
Q2 2024

A detailed history of Cornerstone Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cornerstone Advisors, LLC holds 3,600 shares of BIIB stock, worth $704,268. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,600

Previous 6,500 44.62%

Holding current value

$704,268

Previous $1.4 Million 40.47%

% of portfolio

0.03%

Previous 0.06%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$190.52 - $236.72 $552,508 - $686,488	-2,900 Reduced 44.62%	3,600 $834,000
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $1 Million - $1.21 Million	-4,500 Reduced 40.91%	6,500 $1.68 Million
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $1.77 Million - $2 Million	-7,000 Reduced 38.89%	11,000 $2.83 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $504,880 - $613,440	2,000 Added 12.5%	18,000 $4.98 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $1.81 Million - $2.9 Million	7,000 Added 77.78%	16,000 $5.54 Million
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $2.19 Million - $2.56 Million	9,000 New	9,000 $2.52 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $2.83 Million - $4.26 Million	-11,965 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $1.05 Million - $1.21 Million	3,965 Added 49.56%	11,965 $3.39 Million
Q2 2020 Aug 11, 2020	BUY	$258.66 - $342.55 $2.07 Million - $2.74 Million	8,000 New	8,000 $2.14 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisors, LLC with notifications on news.

Account

Cornerstone Advisors, LLC Biogen Inc. Transaction History